Skip to content

Frontlight ResearchEarly access

Trial site

Local Institution - 012-733

Liuzhou, Guangxi 545006, ChinaNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Lung cancer

Running trials

Active, not recruiting
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
NCT04685135· Phase 3· Mirati Therapeutics Inc.· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Local Institution - 012-733: trial site – Frontlight Research